9-chloro-5-(pyridin-3-ylmethyl)imidazo[1,5-a]quinoxalin-4(5H)-one

ID: ALA5282970

Chembl Id: CHEMBL5282970

Max Phase: Preclinical

Molecular Formula: C16H11ClN4O

Molecular Weight: 310.74

Names and Identifiers

Canonical SMILES:  O=c1c2cncn2c2c(Cl)cccc2n1Cc1cccnc1

Standard InChI:  InChI=1S/C16H11ClN4O/c17-12-4-1-5-13-15(12)21-10-19-8-14(21)16(22)20(13)9-11-3-2-6-18-7-11/h1-8,10H,9H2

Standard InChI Key:  BRFUYNWSKXSYOM-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5282970

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 310.74

Molecular Weight (Monoisotopic): 310.0621

AlogP: 2.75

#Rotatable Bonds: 2

Polar Surface Area: 52.19

Molecular Species: NEUTRAL

HBA: 5

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 4.81

CX LogP: 1.75

CX LogD: 1.75

Aromatic Rings: 4

Heavy Atoms: 22

QED Weighted: 0.57

Np Likeness Score: -1.32

References

1. Károlyi BI, Potor A, Kapus GL, Fodor L, Bobok A, Krámos B, Magdó I, Bata I, Szabó G..  (2023)  Novel imidazo[1,5-a]quinoxaline derivatives: SAR, selectivity and modeling challenges en route to the identification of an α5-GABAA receptor NAM.,  80  [PMID:36549396] [10.1016/j.bmcl.2022.129107]

Source

Source(1):

• Scientific Literature